How does Veopoz treat CHAPLE?

What does Veopoz target in CHAPLE?

The provided information does not state what “Veopoz” is, what “CHAPLE” refers to, or how Veopoz treats CHAPLE.

What’s missing to answer “how it treats”?

To explain the mechanism and clinical use, I need at least one of the following:
- The full spelling of “CHAPLE” (or what condition it stands for)
- The generic name of Veopoz (and ideally the company)
- Any source link or label text describing Veopoz’s indication

Can you share a label, country, or drug name?

If you paste a bit of the product label, a regulator page (FDA/EMA/etc.), or a DrugPatentWatch.com link for Veopoz, I can describe:
- the drug’s mechanism,
- what stage/severity of CHAPLE it’s used for,
- dosing approach (if available),
- and the main benefits and risks tied to that indication.

Sources: None (no usable provided information).